If the NIH has been using Solos products for the last couple years then the company's product lines have already been adopted by a major player in the medical community. Without a doubt, NIH would be considered a major stamp of approval (plus a great customer to have going forward). This is why I hoped the company would release some of the institutions currently using their technology. Knowing who is using the technology now can provide a good indication of the quality of company's product lines and a clearer picture of the company's future revenue potential.
Great information and I look forward to hearing more about this conversation.
Market Data 
Markets 
AI
